Cincinnati Children’s Hospital Medical Center has selected its current COO, Dr. Steve Davis, who succeeds longtime president and CEO Michael Fisher on November 22.
Fischer, 62, announced plans to retire in April after 12 years as head of a major pediatric provider. Fischer said at the time that he would stay until the health care system chooses a permanent replacement.
Davis, 59, served for six months in 2018 as interim CEO of Cincinnati Children’s. He joined the organization in 2015 after serving as Chief Operating Officer of Cleveland Clinic Hillcrest from 2012 to 2015. From 1996 to 2015, Davis worked as a pediatric resuscitator at the Children’s Hospital of the Cleveland Clinic.
During his tenure at the Cleveland Clinic, Davis held a variety of leadership positions, including Director of the Pediatric Intensive Care Fellowship Program, Chair of Pediatric Intensive Care Medicine, and Executive Director of Critical Health Care.
“I came to Cincinnati Children’s because I want to change the healthcare world – for children in Cincinnati and beyond,” Davis said in a press release. “I envision a world in which all children can reach their full potential – where racial and economic differences have been eliminated, and where the zip code you were born in does not shorten your life expectancy or quality of life.”
Cincinnati Children’s Board formally approved the decision in a vote on Monday, Chairman of the Board Mark Jahnke said in a press release. According to Jahnke, Davis’s experience as a clinician and leader made him “the obvious choice.” “Steve brings exceptional problem solving skills and a collaborative spirit to the CEO position,” Jahnke said.
Davis will take over the management of one of the largest healthcare providers in the region. Cincinnati Children’s employs over 16,000 people and has annual operating income of $ 2.6 billion. The new CEO has stepped up telemedicine services during the COVID-19 pandemic and recently led the construction of a $ 600 million intensive care medical center building to serve patients with cancer, heart disease and other complex illnesses, scheduled to open November 6.